Pfizer Medicare Part D Formulary Placement: Bundled Up, Or Out In The Cold?

Pfizer appears to have taken an all-or-nothing approach to negotiating formulary positioning for its products in Medicare Part D prescription drug plans, according to an analysis by "The Pink Sheet" of plan formularies